1 Min Read
May 15 (Reuters) - MMJ Phytotech Ltd
* MMJ receives approval to conduct MS phase 2 clinical trials Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.